Polaris Industries Inc. (NYSE:PII) Posts Quarterly Earnings Results
Featured Stock: Freeport-McMoRan Inc. (FCX)
Most Recent Analysts Ratings Whiting Petroleum Corp. (WLL)
Should Trump allow Abbie's father to come to USA for her funeral?
Has $5.98 Million Stake in Encana Corporation (NYSE:ECA)
Drug developed in Manitoba could fight antibiotic-resistant bacteria
22 April 2017, 01:29 | Jan Cross
Research on the antibiotic drug PEG-2S shows that it can offer a way to fight antibiotic resistance without damaging healthy cells
There may be a new weapon in the battle against antibiotic-resistant infections, thanks to some Manitoba scientists.
Although the threat of drug-resistant bacteria is rising, no new class of antibiotics has been approved in 30 years. Because a number of bacteria rely on the NQR pump for energy, PEG-2S could be a boon in the fight against drug-resistant bacteria.
Pseudomonas aeruginosa is often acquired by people with weakened immune systems in hospitals.
Grant Pierce, executive director of research at St. Boniface Hospital and a professor at the University of Manitoba, said that PEG-2S is created to attack bad bacteria without affecting healthy human cells. "We have not only defined a new and effective target, we have designed a drug to attack it without affecting normal cells".
"So it's a breakthrough in that it's attacking a completely different target", he said.
The research suggests the drug can target at least two of the top 10 priority pathogens listed by the World Health Organization.
Pair tasered after chase in Melbourne
A wanted man has been Tasered and arrested by police after a dramatic early-morning high-speed vehicle chase on Punt Road. Police said they used a Taser and capsicum spray to arrest a man and woman at the scene.
Three soldiers killed by Boko Haram IED in Borno
He said troops recovered AK 47 rifles, nine rounds of ammunition and 22 rounds of North Atlantic Treaty Organisation ammunition. Enenche was holding a seminar with defence correspondents and will revert back as soon as possible.
Dr Pierce told a Canadian TV news channel that the antibiotic could kill bacteria that causes Legionnaires' disease, cholera, typhoid fever and bubonic plague.
It is the first antibiotic discovered since 1987.
Pierce said the development of PEG-2S is "novel and exciting", although it's still in the laboratory stage.
The two doctors have applied for patent approval from the U.S. Food and Drug Administration. They then plant to begin testing on animals and, provided those tests go well, trials on humans.
The research was published in the Canadian Journal of Physiology and Pharmacology.
Warning for pressures on Lancashire police
The people of Gwent should be proud of the Force's performance and for the good level of service it provides. Getting this right can be not just life changing but life saving".
Most Active Stock: KB Home (KBH)
The analysts offering Earnings Estimates for the company were believing that KB Home (KBH ) could bring EPS of $0.13/share. It operates through five segments, which consist of four homebuilding segments and one financial services segment.
Should Investors Sell on Philip Morris' Q1 Miss?
Despite promising signs about the company's long-term future, few shareholders were happy with Philip Morris' current situation. Equities research analysts forecast that Philip Morris International will post $4.87 earnings per share for the current year.
Pence in Indonesia With Trade on Agenda
National Security Agency's mass surveillance, published the coup article by freelance journalist Allan Nairn earlier this week. He paved the way for a bigger US military presence in the Philippines, where American bases were shuttered 25 years ago.
BHP Billiton Limited (NYSE:BHP) Reviewed By Analysts
BHP Billiton PLC (LON:BLT) had its stock rating reiterated as "Equal weight" in a report released by analysts at Barclays Capital. Commerzbank Aktiengesellschaft FI's holdings in BHP Billiton Limited were worth $5,664,000 at the end of the most recent quarter.